Neha Krishnamohan - 15 Nov 2025 Form 4 Insider Report for Artiva Biotherapeutics, Inc. (ARTV)

Key filing fact

Neha Krishnamohan filed Form 4 for Artiva Biotherapeutics, Inc. (ARTV) on 17 Nov 2025.

Key facts

This page summarizes Neha Krishnamohan's Form 4 filing for Artiva Biotherapeutics, Inc. (ARTV).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 17 Nov 2025, 20:38.

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

CIK 0001866171 Primary reporting owner

Relationship: Chief Financial Officer
Address: C/O ARTIVA BIOTHERAPEUTICS, INC., 5505 MOREHOUSE DRIVE, SUITE 100, SAN DIEGO
Signature: /s/ Neha Krishnamohan
Signature date: 17 Nov 2025

Shares, units, or other non-derivative securities reported in this filing.

ARTV transaction

Tax liability

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Explanation of responses 1 footnote

Footnote F1

Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of restricted stock unit awards.